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Abstract 
Three triorganotin(IV) complexes of composition R3SnLH (R = Me, Bu and Ph and LH 
= 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-diazenyl]benzoate) have been synthesized and 
characterized by 1H-,13C-, 119Sn- NMR, and IR spectroscopic techniques in combination with 
elemental analysis. The crystal structures of the carboxylate ligand HO2CC6H4{N=N(C6H2-4-
OH-3,5-(CH3)2)}-o in its neutral form and three triorganotin(IV) complexes, viz., polymeric 
(R3Sn[O2CC6H4{N-N(H)(C6H2-4-O-3,5-(CH3)2)}-o])n  (R = Me (1) and Bu (2)) and 
monomeric Ph3Sn[O2CC6H4{N-N(H)(C6H2-4-O-3,5-(CH3)2)}-o] (3) complexes are reported. 
The polymeric complexes 1 and 2 exist as extended chains in which the LH-bridged Sn-atoms 
adopt a trans-R3SnO2 trigonal bipyramidal configuration with R groups in the equatorial 
positions and the axial sites occupied by an oxygen atom from the carboxylate ligand and the 
phenoxide O atom of the next carboxylate ligand. The Sn atom in complex 3 has a distorted 
tetrahedral geometry. In all three complexes, the carboxylate ligand is in the zwitterionic form 
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with the phenolic proton moved to the nearby azo nitrogen atom, in contrast to the free 
carboxylic acid ligand which is in the azo form. 
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1. Introduction  
 
Recently, we have investigated the crystal structures of 2-[(E)-(5-tert-butyl-2-
hydroxyphenyl)diazenyl]benzoic acid [1] and 4-[(E)-(5-tert-butyl-2-
hydroxyphenyl)diazenyl]benzoic acid [2], which featured essentially a planar diazo molecule 
with an E conformation about the N=N bond and centrosymmetrically related molecules associate 
into dimers via the eight-membered dicarboxylic acid {···H-O-C=O}2 synthon. Further, these 
ligands and their analogues have been explored for their coordination behaviour towards 
organotin(IV) in order to find possible candidates in this class of organotin(IV) complexes which 
might act as anticancer drugs owing to their remarkable cytotoxic activity that has been exhibited 
in some cases across a panel of cell lines [3-5]. As a result of promising cytotoxic activity [6,7], 
the mechanistic role of these organotin(IV) compounds was investigated, to see influence of the 
azo group nitrogen atoms, by docking studies with some of the key enzymes such as 
ribonucleotide reductase, thymidylate synthase, thymidylate phosphorylase and topoisomerase II 
that take part in the synthesis of raw materials for DNA and its replication [3-5]. The docking 
studies indicated that the azo group nitrogen atoms and formyl, carbonyl and ester oxygen atoms 
in the ligand moiety play an important role. They exhibit hydrogen bonding interactions with the 
active site of the amino acids of the aforementioned enzymes. The higher activity was attributed 
to the presence of the azo group nitrogen atoms in the triphenyltin(IV) complexes [4]. In addition, 
triorganotin(IV) carboxylates of the general formula R3Sn(O2CR´) are of great interest because of 
their structural diversity in the crystalline state [8]. Recently, the crystal structure of 
tributyltin(IV) 4-[(E)-(4-hydroxy-3-methylphenyl)diazenyl]benzoate revealed that the Sn atom 
has a distorted C3O tetrahedral geometry involving one of the carboxylate O atoms and three C 
atoms from the butyl ligands [3]. On the other hand, its ortho-carboxy analogue i.e. 
tributyltin(IV) 2-[(E)-(4-hydroxy-3-methylphenyl)diazenyl]benzoate demonstrated an 
unprecedented structure where the tributyltin centre is coordinated by a carboxylate anion (in a 
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quinoid form) as well as by its neutral form (coordinating as a ketone) [9]. The tin atom in this 
complex is five coordinate within a trans-C3O2 donor set. In the crystal structure, two complex 
molecules self assemble via O–H…O hydrogen bonding leading to the formation of 48-
membered macrocyclic rings [9]. Subsequently, the crystal structures of three triphenyltin(IV) 2-
/4-[(E)-2-(aryl)-1-diazenyl]benzoates have been determined and all of them conform to the same 
motif, i.e. a distorted tetrahedral geometry [10]. In view of the synthetic and structural importance 
and the potential biological activity of the triorganotin(IV) complexes of the aforementioned 
ligands, it is of interest to explore the chemistry of the analogous ligands towards triorganotin(IV) 
where now the carboxylate ligand is 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-
diazenyl]benzoate (LH) (Fig. 1). Three triorganotin(IV) complexes of composition R3SnLH (R = 
Me, Bu and Ph) have been characterized by means of IR, 1H-, 13C- and 119Sn- NMR spectroscopic 
studies. The crystal and molecular structures of ligand LHH’, [Me3SnLH]n (1), [Bu3SnLH]n (2) 
and Ph3SnLH (3) are also reported.   
 
2. Experimental 
2.1. Materials 
Ph3SnOH was prepared from Ph3SnCl (Fluka) by following the literature method [11]. 
(Bu3Sn)2O (Merck), Me3SnCl (Merck), 2,6-dimethylphenol (Aldrich) and o-aminobenzoic acid 
(Aldrich) were used without further purification. The solvents used in the reactions were of AR 
grade and dried using standard procedures. Toluene was distilled from sodium benzophenone 
ketyl.  
 
2.2. Physical measurements 
 Carbon, hydrogen and nitrogen analyses were performed with a Perkin Elmer 2400 series 
II instrument. IR spectra in the range 4000-400 cm–1 were obtained on a Perkin Elmer Spectrum 
BX series FT-IR spectrophotometer with samples investigated as KBr discs. The 1H, 13C and 
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119Sn NMR spectra were recorded either on a Bruker AMX 400 or on a Varian Mercury 400 
spectrometer and measured at 400.13, 100.62 and 149.32 MHz, respectively. The 1H, 13C and 
119Sn chemical shifts were referenced to Me4Si and Me4Sn set at 0.00, ppm, respectively.  
 
2.3. Synthesis of the ligand and its triorganotin(IV) complexes  
 
2.3.1. Synthesis of 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-diazenyl]benzoic acid (LHH’)   
o-Aminobenzoic acid (5.0 g, 36.5 mmol) was mixed with HCl (5 ml) and water (16 ml) 
and digested on a water bath for 30 min. The hydrochloride was cooled to 5 °C and diazotized 
with ice-cold aqueous NaNO2 solution (2.5 g, 20 ml). A cold solution of 2,6-dimethylphenol 
(4.45 g, 36.5 mmol), previously dissolved in 10% NaOH solution (50 ml), was then added to the 
cold diazonium salt solution with vigorous stirring. A red colour developed almost immediately 
and the stirring was continued for 1 h. The reaction mixture was kept overnight in a refrigerator, 
followed by 3 h. at room temperature, and then acidified with dilute acetic acid, whereupon a 
yellow orange precipitate separated out. The precipitate was filtered, washed several times with 
water to remove excess acetic acid and water-soluble materials, and then dried in air. The crude 
product was washed with hexane to remove any tarry materials, dried in vacuo and recrystallized 
from methanol to yield yellow prismatic crystals of LHH’ (2.25g, 50%). M.p.: 212–214 °C. Anal. 
Found: C, 66.74; H, 5.30; N, 10.43%. Calcd. For C15H14N2O3:  C, 66.66; H, 5.22; N, 10.36. IR 
(cm-1): 1679 (OCO)asym. 1H-NMR (DMSO-d6); δH: 13.1 [CO2H], 9.23 [OH], 7.73 [d, 7.5 Hz, 1H, 
H-3], 7.62 [t, 7.5 Hz, 1H, H-4], 7.52 [m, 4H, H-5, 6, 2’ and 6’], 2.25 [s, 6H, CH3], ppm. 13C-
NMR (DMSO-d6); δC: 169.3 [CO2], 158.0 [C-4’], 151.5 [C-1], 145.6 [C-1’], 132.1 [C-5], 130.0 
[C-4], 129.7 [C-3], 125.6 [ C-6, C-2’ and 6’], 124.3 [C-3’and 5’], 118.8 [C-2], 17.4 [CH3], ppm.  
The sodium salt of the ligand (LHNa) was prepared by adding an aqueous solution of 
sodium hydrogen carbonate into pre-dissolved ligand in ethanol in an equimolar ratio. The 
solution was stirred for 2 h under mild heating conditions and was evaporated under reduced 
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pressure to give a red solid which was dried in vacuo. The dried sodium salt was extracted in 
anhydrous methanol and filtered while hot, which upon concentration afforded LHNa in 50% 
yield.  This product was used for the subsequent reactions. IR (cm-1): 1629 (OCO)asym. 
 
2.3.2. Synthesis of Me3SnLH (1)  
 Me3SnCl (0.43 g, 2.16 mmol) in anhydrous methanol (50 ml) was added drop-wise with 
continuous stirring to a hot methanol solution (50 ml) containing LHNa (0.60 g, 2.16 mmol). The 
reaction mixture was then refluxed for 5 h and filtered while hot. The filtrate was kept for 
crystallisation. Red crystals were obtained the following day. M.p.: 246-248 °C. Yield 0.05 g, (30 
%). Anal. Found: C, 50.61; H, 5.11; N, 6.36%. Calcd. For C18H22N2O3Sn: C, 49.92; H, 5.12; N, 
6.47%. IR (cm-1): 1626 (OCO)asym. 1H-NMR (CDCl3); δH: 12.8 [s, 1H, OH], 8.05 [d, 7.5 Hz, 1H, 
H-3], 7.84 [d, 8.8 Hz, 1H, H-6], 7.51 [t, 7.2 Hz, 1H, H-4], 7.31 [s, 1H, H-2’], 7.18 [s, 1H, H-6’], 
7.00 [t, 8 Hz, 1H, H-5], 2.16 and 2.07 [s, 6H, CH3]; Sn-Me: 0.70 [s, 9H, Sn-CH3][ [2J(1H-
119/117Sn) 60 Hz)], ppm. 13C-NMR (DMSO-d6); δC: 169.5 [CO2], 154.3 [C-4’], 147.7 [C-1], 134.3 
[C-1’], 126.8 [C-4 and 5], 125.7 [C-3], 122.5 [ C-6], 121.4 [C-2’, 6’, 3’ and 5’], 114.0 [C-2], 14.8 
[CH3]; Sn-Me: -1.76 [Sn-CH3] [1J(13C-119/117Sn) 513 Hz)], ppm. 119Sn-NMR (CDCl3): 149.6 ppm.  
 
2.3.3. Synthesis of Bu3SnLH (2)  
Compound 2 was synthesized by refluxing a 2:1 molar ratio of LHH’ (0.50 g, 1.95 mmol) 
and (Bu3Sn)2O (0.58 g, 0.97mmol) in 50 ml of anhydrous toluene in a 100 ml flask equipped with 
a Dean–Stark moisture trap and a water-cooled condenser. The reaction mixture was refluxed for 
5 h. The solvent was distilled off to half of the initial solvent volume. The remaining solvent was 
removed using a rotary evaporator. The dark-red residue was then dissolved in 20 ml of hexane 
and filtered to give, upon refrigeration, the crude product. Dark red crystals were isolated by 
recrystallisation from toluene/hexane. M.p: 120-122 °C. Yield (0.57 g) 35%. Anal. Found: C, 
58.10; H, 7.37; N, 4.98%. Calcd. For C27H40N2O3Sn: C, 57.98; H, 7.21; N, 5.01%. IR (KBr): 
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1633 cm-1 (OCO)asym. 1H-NMR (CDCl3); δH: 12.9 [s, 1H, OH], 8.04 [d, 7.5 Hz, 1H, H-3], 7.82 [d, 
8.8 Hz, 1H, H-6], 7.50 [t, 7.2 Hz, 1H, H-4], 7.34 [s, 1H, H-2’], 7.18 [s, 1H, H-6’], 7.00 [t, 8 Hz, 
1H, H-5], 2.16 and 2.07 [s, 6H, CH3]; Sn-Bu: 1.71 [m, 6H, H(α)], 1.38 [m, 12H, H(β) and H(γ)], 0.93 
[t, 7.5 Hz, 9H, H(δ)], ppm. 13C-NMR (CDCl3); δC: 187.3 [CO2], 173.1 [C-4’], 144.8 [C-1], 138.9 
[C-1’], 137.8 [C-5], 136.9 [C-4], 134.7 [C-3], 134.1 [C-6], 132.4 [C-2’], 121.2 [C-6’], 119.1 [C-
3’], 114.7 [C-5’], 113.8 [C-2], 17.5 and 16.1 [CH3]; Sn-Bu: 27.8 [C(β)][2J(13C-119/117Sn) 21 Hz)], 
27.0 [C(γ)][3J(13C-119/117Sn) 65 Hz)], 17.0 [C(α)][1J(13C-119/117Sn) 354 Hz)], 13.7 [C(δ)], ppm. 119Sn-
NMR (CDCl3): 126.2 ppm.  
 
2.3.4. Ph3SnLH (3) 
Compound 3 was synthesized by reacting LHH’ (0.73 g, 2.04 mmol) and Ph3SnOH (0.75 g, 2.04 
mmol) in 50 ml of anhydrous toluene by following the method described for compound 2. The 
filtrate was collected and the volatiles were removed using a rotary evaporator. The residue was 
dried in vacuo, washed with hexane (3×5 ml), extracted into chloroform and filtered. The filtrate 
upon concentration afforded the crude product. The crude product was dried in vacuo and 
recrystallized from toluene to yield orange crystals of the desired product. M.p.: 190-192 ºC. 
Yield (0.07 g, 30%). Anal. Found: C, 64.71; H, 4.65; N, 4.51%. Calcd. For C33H28N2O3Sn: C, 
64.00; H, 4.56; N, 4.52%. IR (KBr): 1638 cm-1 (OCO)asym. 1H NMR (CDCl3): 12.7 [s, 1H, OH], 
8.15 [d, 7.5 Hz, 1H, H-3], 7.30 [s, 1H, H-2’], 7.14 [s, 1H, H-6’], 7.00 [t, 8 Hz, 1H, H-5], 2.15 and 
2.06 [s, 6H, CH3]; Sn-Ph: 7.81[m, 7H, Sn-Ph(o) and H-6], 7.50 [m, 10H, Sn-Ph(m+p) and H-4], ppm. 
13C-NMR (CDCl3); δC: 187.3 [CO2], 174.2 [C-4’], 145.0 [C-1], 139.1 [C-1’], 138.1 [C-5], 134.9 
[C-4], 134.8 [C-3], 132.7 [C-6], 121.3 [C-2’ and 6’], 119.1 [C-3’ and 5’], 113.9 [C-2], 17.7 and 
16.1 [CH3]; Sn-Ph: 138.0 [C(i)][1J(13C-119/117Sn) 630 Hz)], 136.8 [C(o)][2J(13C-119/117Sn) 50 Hz)], 
130.3 [C(p)][4J(13C-119/117Sn) 13 Hz)], 129.1 [C(m)][3J(13C-119/117Sn) 65 Hz)], ppm. 119Sn NMR 
(CDCl3): -104.0 ppm.  
 8 
Note: α, β, γ and δ denote the proton and carbon numbers of tin-butyl while i-, o-, m- and p- refer 
to the proton and carbon numbers of tin-phenyl groups. 
 
2.4. X-ray crystallography 
Crystals of compounds suitable for an X-ray crystal-structure determination were 
obtained from methanol (LHH’), toluene/chloroform/hexane (1), hexane (2) and toluene (3) by 
slow evaporation of the solvent at room temperature. The measurements for 1-3 were made at low 
temperature on a Nonius KappaCCD diffractometer [12] with graphite-monochromated Mo Kα 
radiation (λ = 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. The data for LHH’ 
were recorded on an Agilent Technologies SuperNova area-detector diffractometer [13] using Cu 
Kα  radiation (λ = 1.54184 Å) from a micro-focus X-ray source and an Oxford Instruments 
Cryojet XL cooler. Data reduction on 1-3 was performed with HKL Denzo and Scalepack [14] 
while CrysAlisPro [13] was used for LHH’. The intensities were corrected for Lorentz and 
polarization effects. An empirical absorption correction based on the multi-scan method was 
applied for 1-3 [15], and LHH’ [13]. Equivalent reflections were merged. The data collection and 
refinement parameters are given in Table 1, and views of the structures 1-3 (segments of the 
polymeric structures in the case of 1 and 2) are shown in Figs. 2-4.  
The structures of 1-3 were solved by heavy-atom Patterson methods [16], followed by the 
Fourier expansion routine of DIRDIF94 [17] while the structure of LHH’ was solved by direct 
methods by using SHELXS97 [18].  
Complex 1 crystallises as a 1:1 solvate with CHCl3. The asymmetric unit of compound 2 
contains four independent repeats of the chemically unique fragment, which generate three 
symmetry-independent polymeric chains. The terminal methyl group of one butyl ligand in one 
residue is disordered over two conformations. Two positions were defined for this methyl group 
and the site occupation factor of the major conformation of these groups refined to 0.600(9). 
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Similarity restraints were applied to the chemically equivalent bond lengths involving the 
disordered C-atoms. The non-hydrogen atoms in each structure were refined anisotropically. The 
amine H-atoms in 1-3 and the hydroxy H-atoms in LHH’ were placed in the positions indicated 
by difference electron density maps and their positions were allowed to refine together with 
isotropic displacement parameters. All remaining H-atoms were placed in geometrically 
calculated positions and refined using a riding model where each H-atom was assigned a fixed 
isotropic displacement parameter with a value equal to 1.2Ueq of its parent C-atom (1.5Ueq for the 
methyl groups). The refinement of each structure was carried out on F2 by using full-matrix least-
squares procedures, which minimized the function Σw(Fo2 – Fc2)2.  Corrections for secondary 
extinction were applied for 1 and 3. Seven reflections for 2 and one reflection for 3 whose 
intensities were considered to be extreme outliers, were omitted from the final refinement. All 
calculations were performed using the SHELXL97 program  [18].  The crystallographic diagrams 
were drawn using ORTEPII [19]. 
3. Results and discussion 
 
3.1. Spectroscopy 
 Diagnostically important infrared absorption frequencies for the carboxylate 
antisymmetric [νasym(OCO)] stretching vibration of the trorganotin complexes (1-3) are given in 
Section 2.3. The assignment of the symmetric [νsym(OCO)] stretching vibration band could not be 
made owing to the complex pattern of the spectra. The antisymmetric [νasym(OCO)] stretching 
vibration band of the uncomplexed ligands (LHH’) appears at ∼1680 cm-1. For the triorganotin 
complexes, the corresponding carbonyl stretching frequency appears at ∼1630 cm-1. The shift of 
the band in 1-3 relative to its position for the free ligand is ascribed to carboxylate coordination to 
the tin atom in accordance with earlier reports [3-5,20-22].  
 The 1H- and 13C- NMR data of LHH’ and triorganotin(IV) complexes 1-3 are reported in 
Section 2.3. The NMR signals of LHH’ were assigned from the multiplicity patterns, resonance 
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intensities and also by comparing the NMR spectrum with those of the cognate ligands [1,3-5]. 
The conclusions drawn from the ligand assignments were then subsequently extrapolated to the 
complexes owing to the data similarity. The 1H- and 13C- chemical shift assignments of the 
triorganotin moiety are straightforward from the multiplicity patterns, resonance intensities and 
also by examining the nJ(13C-119/117Sn) coupling constants [21-23]. The 1H-NMR integration 
values were completely consistent with the formulation of the products. The 119Sn-NMR chemical 
shifts of the complexes (1-3) in CDCl3 solution are listed in Section 2.3. Complexes 1-3 exhibit a 
single sharp resonance at ca. 149, 126 and -104 ppm, respectively, suggesting that the tin atom is 
four-coordinate [3,4,20-23]. In contrast, the solid-state polymeric structures found for complexes 
1 and 2, reveal five-coordinate tin atoms (vide infra). It is anticipated that the multinuclear 
structures break down in solution to generate monomeric four-coordinate tetrahedral complexes 
[23].  
3.2. X-ray crystallography 
The crystal structure of LHH’ is shown in Fig. 2, while selected geometric parameters are 
collected in Table 2. The molecule is approximately planar with just small twists about the central 
C–N bonds linking the two phenyl rings, as indicated by the torsion angles N(2)-N(1)-C(7)-C(6) 
= -12.14(12)º and N(1)-N(2)-C(8)-C(9) = 3.63(13)º. The carboxylic acid group is coplanar with 
its parent phenyl ring [O(1)-C(1)-C(2)-C(3) = -177.17(8)º]. The carboxylic acid H-atom forms an 
intramolecular hydrogen bond with the azo N-atom closest to the carboxylic acid group. The 
hydroxy group forms an intermolecular hydrogen bond with the carboxylic acid carbonyl O-atom 
of a neighbouring molecule and thereby links the molecules into extended chains which run 
parallel to the [201] direction (Table 3). The intra- and intermolecular hydrogen-bonding patterns 
can be described by graph set motifs [24] of S(6) and C(12), respectively. Pairs of molecules 
related by  a two-fold axis have their planes less than 3.5 Å apart, but the antiparallel nature of the 
molecules precludes any π···π interactions between adjacent phenyl rings. Nonetheless, azo N 
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atoms in adjacent molecules come into close proximity: N(1)···N(1)i = 3.2869(11); N(1)···N(2)i = 
3.4702(11) Å (symmetery code (i): 2-x, y, 1/2-z). These pairs of molecules are further connected 
to form a stack of molecules parallel to the [001] direction by two weak C–H···π interactions 
between adjacent pairs related by a center of inversion. Thus, methyl group C(14)–H(142) of the 
hydroxyphenyl ring interacts with the centroid of the phenyl ring defined by atoms C(2) to C(7) 
in the molecule at the symmetry-related position 2-x, -y, 1-z, and this latter molecule has an 
identical interaction back to the original molecule (H···π = 2.96 Å, C–H···π = 151°). Finally, two 
C–H···O interactions serve to complete the three-dimensional supramolecular structure. The 
C(5)–H(5)···O(1)ii interaction between the hydroxyphenyl ring and the carboxylic acid O-atom 
links the molecules into extended chains which run parallel to the [010] direction; graph set motif 
C(7) (H(5)···O(1)ii = 2.50 Å, C(5)–H(5)···O(1)ii = 160°; symmetery code (ii): 3/2-x, y-1/2, 1/2-z). 
The C(3)–H(31)···O(3)iii interaction between the benzoate phenyl ring and the hydroxyphenyl O-
atom also links the molecules into extended chains, this time running parallel to the [-102] 
direction and producing a graph set motif of C(11) (H(31)···O(3)iii = 2.35 Å, C(3)–H(31)···O(3)iii 
= 163°; symmetery code (iii): x-1, -y, z-1/2). 
The one-dimensional polymeric structures of compounds 1 and 2 are shown in Figs. 3 
and 4, while selected geometric parameters are collected in Table 4. The crystal structures of 
complexes 1 and 2 are very similar and exhibit the same structural motif of a polymeric chain 
where a single carboxylate ligand bridges adjacent trans-R3SnO2 centres via its carboxylate and 
phenoxide O-atoms. It should be mentioned here that a neutral monomeric structure for a 
tributyltin(IV) complex with a trans-R3SnO2  motif was recently reported for an analogous ligand 
2-[(E)-2-(4-hydroxy-3-methylphenyl)-1-diazenyl]benzoate. In this complex, the tributyltin centre 
is coordinated by both a carboxylate anion, which exists in a quinoid form, as well by the neutral 
form of the ligand, which coordinates as a ketone [9].  
The asymmetric unit in 1 contains one chemical repeat of the polymer, plus one molecule 
of chloroform, while four independent chemical repeat units from each of three symmetry-
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independent polymeric chains (designated A, B, C and D) is present in the asymmetric unit of 2. 
Fragments A and B form independent chains each composed of just A or B residues. Fragments C 
and D alternate within the third independent chain. Residue B has disordered positions for the 
methyl group of one butyl ligand. There is possible disorder in a second butyl ligand, but this was 
not modelled. The primary coordination sphere of the Sn-atom is trigonal bipyramidal with the 
Sn-R (R = Me or Ph) ligands in the equatorial plane and axial positions occupied by one O-atom 
from the carboxylate group of one ligand and the phenoxide O-atom (formerly the hydroxy 
group, see structure of LHH’ in Fig. 2) of the next carboxylate ligand in the chain. The formal 
hydroxy group of the azo ligand LHH’ in these complexes has lost its H-atom, so is negatively 
charged. Instead, the azo N-atom nearest the carboxylate group is protonated, thus leading to a 
quinoid type zwitterionic ligand. This N-H group forms an intramolecular hydrogen bond with 
the carboxylate carbonyl O-atom. The carbonyl O-atom of the carboxylate group coordinates very 
weakly via a very long bond to the Sn-atom (3.081(2) Å in 1 and in the range 3.045(2)-3.079(3) 
Å in 2). In 1 and 2, the second O-atom of the carboxylate group is not involved in the primary 
coordination sphere of the Sn-atom, although these distances are still within the sum of the van 
der Waals radii of the respective atoms (ca. 3.6 Å). There are only very small distortions of the 
trigonal bipyramidal Sn-coordination geometry as a result of the Sn···O(2) contact (Table 2). A 
polymeric structure with a similar mode of coordination and geometry about the Sn-atom was 
observed in the triorganotin(IV) complexes with 2-{[(E)-1-(2-
hydroxyphenyl)methylidene]amino}acetate [25], 2-{[(2Z)-(3-hydroxy-1-methyl-2-
butenylidene)]amino}phenylpropionate [26], 2-{[(E)-1-(2-hydroxyphenyl)methylidene]-
amino}phenylpropionate [26], 2-{[(E)-1-(2-hydroxyphenyl)ethylidene]amino}phenylpropionate 
[26], 2-{[(2Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}-4-methyl-pentanoate [27], 2-{[(E)-
1-(2-hydroxyphenyl)alkylidene]amino}-4-methylpentanoates [27] and 4-[(2Z)-(3-hydroxy-1-
methyl-2-butenylidene)amino]benzoates [28].   
The polymeric structures found for 1 and 2 are not repeated in the structure of 3 in which  
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discrete monomeric Sn-complex molecules are present (Fig. 5). The Sn-atom is coordinated by 
one of the carboxylate group oxygen atoms of the ligand and three phenyl groups. Thus, the tin 
atom in 3 is four coordinate with a distorted tetrahedral geometry defined by a C3O donor set 
(Table 4). The range of the tetrahedral angles at the Sn atom is 97.50(6) to 118.35(6)º. The 
carboxylate carbonyl O-atom, O(2), interacts only weakly with the Sn-atom at a distance of 
2.778(1) Å and this is reflected in the disparity in the C(1)-O(1) and C(1)-O(2) bond distances, 
i.e., 1.306(2) and 1.244(2) Å, respectively. This interaction is the cause of the distortion of the 
tetrahedral primary coordination sphere, but the Sn(1)···O(2) distance is considered to be too long 
for the Sn atom to be described as truly five-coordinate. In addition, the bond angles around the 
Sn atom in 3 are more consistent with a tetrahedral environment than with a trigonal bipyramidal 
five-coordinate environment. Similar tetrahedral geometry about the Sn atom to that of 3 was 
observed in triphenyltin(IV) complexes with 2-[(E)-2-(2-hydroxy-5-methylphenyl)-1-
diazenyl]benzoate and its acetone solvated complex [29,30], 5-[(E)-2-(aryl)-1-diazenyl]-2-
hydroxybenzoates [21,22,31], 2-[(E)-(5-tert-Butyl-2-hydroxyphenyl)-diazenyl]benzoate, 4-[(E)-
(5-tert-Butyl-2-hydroxyphenyl)-diazenyl]benzoate and 4-[(E)-2-(2-hydroxy-5-methylphenyl)-1-
diazenyl]benzoate [10].  
The carboxylate ligands of pairs of molecules related by a centre of inversion lie parallel 
and head-to-tail and exhibit π···π interactions between the phenyl rings with a distance between 
the centres of graphity of the rings being 3.5800(12) Å. The interplanar separation is 
approximately 3.35Å. The carboxylate ligand in 3 also exists in a quinoid type zwitterionic form 
and shows the usual intramolecular hydrogen bond involving the carboxylate carbonyl O-atom 
and the protonated azide N-H group, as observed in its methyltin(IV) (1) and butyltin(IV) (2) 
analogues (vide supra) (Table 5). In contrast, the neutral LHH’ molecule does not present itself in 
the quinoid form. The preference for the formation of the zwitterionic form of the ligand in 
complexes may be a result of the coordination of the phenoxide O-atom to the Sn-atom in 1 and 2 
while a steric reason could be ascribed for 3 where such coordination is absent. However, quinoid 
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or zwitterionic forms are quite commonly encountered in similar systems [25-28]. 
   
4. Supplementary material 
 CCDC-824668–824671 contain the supplementary crystallographic data for LHH’ and 
complexes 1-3, respectively. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Acknowledgements 
The financial support of the Department of Science & Technology, New Delhi, India 
(Grant No.SR/S1/IC-03/2005,TSBB), Council of Scientific and Industrial Research, New Delhi, 
India (Grant No. 09/347/(0197)/2011/EMR I, award of a Senior Research Fellowship, AP), the 
University Grants Commission, New Delhi, India through SAP-DSA, Phase-III and Indo-Swiss 
Joint Research Programme, Joint Utilisation of Advanced Facilities (Grant No. JUAF 11, TSBB, 
AL) are gratefully acknowledged.  
 
References 
[1] T.S. Basu Baul, A. Paul, H.D. Arman, E.R.T. Tiekink,  Acta Crystallogr. Sect  E 64 (2008) 
o2125. 
[2] T.S. Basu Baul, A. Paul, E.R.T. Tiekink, Acta Crystallogr. Sect E 66 (2010) o540. 
[3] T.S. Basu Baul, A. Paul, L. Pellerito, M. Scopelliti, C. Pellerito, P. Singh, P. Verma, A. 
Duthie, D. de Vos, R.P. Verma, U. Englert, J. Inorg. Biochem. 104 (2010) 950-966. 
[4] T.S. Basu Baul, A. Paul, L. Pellerito, M. Scopelliti, P. Singh, P. Verma, D. de Vos, Invest. 
New Drugs 28 (2010) 587-599.  
[5] T.S. Basu Baul, A. Paul, L. Pellerito, M. Scopelliti, P. Singh, P. Verma, A. Duthie, D. de Vos, 
E.R.T. Tiekink, Invest. New Drugs 29 (2011) 285-299.  
[6] M. Gielen, E.R.T. Tiekink (Ed.), Metallotherapeutic Drug and Metal-based Diagnostic 
 15 
Agents: 50Sn Tin Compounds and their Therapeutic Potential, Wiley, Chichester, England, 
2005, pp. 421-439 (and references therein)  
[7] M. Gielen, A.G. Davies, K. Pannell, E.R.T. Tiekink (Ed.), Tin Chemistry: Fundamentals, 
Frontiers, and Applications, Wiley-Blackwell, 2008.  
[8] E.R.T. Tiekink, Appl. Organomet. Chem. 5 (1991) 1-21. 
[9] T.S. Basu Baul, A. Paul, E.R.T. Tiekink, Z. Kristallogr. 225 (2010) 153-157. 
[10] T.S.Basu Baul, A. Paul, L. Pellerito, A. Duthie, D. de Vos, R.P. Verma, U. Englert, J. Inorg. 
Biochem. Submitted.  
[11] B. Kushlefsky, I. Simmons, A. Ross, Inorg. Chem. 2 (1963) 187-189. 
[12] R. Hooft, KappaCCD Collect Software, Nonius BV, Delft, The Netherlands, 1999. 
[13] CrysAlisPro, Version 1.171.33.55, Agilent Technologies, Yarnton, Oxfordshire, England, 
2010. 
[14] Z. Otwinowski, W. Minor, in: C.W. Carter Jr., R.M. Sweet (Ed.) Methods in Enzymology, 
Vol. 276, Macromolecular Crystallography, Part A, Academic Press, New York, 1997, pp. 
307-326. 
[15] R.H. Blessing, Acta Crystallogr. Sect A 51 (1995) 33-38. 
[16] P.T. Beurskens, G. Admiraal, G. Beurskens, W.P. Bosman, S. Garcia-Granda, R.O. Gould, 
J.M.M Smits, C. Smykalla, PATTY: The DIRDIF program system, Technical Report of the 
Crystallography Laboratory, University of Nijmegen, The Netherlands, 1992. 
 [17] P.T. Beurskens, G. Admiraal, G. Beurskens, W.P. Bosman, R. de Gelder, R. Israel, J.M.M. 
Smits, DIRDIF94: The DIRDIF program system, Technical Report of the Crystallography 
Laboratory, University of Nijmegen, The Netherlands, 1994. 
[18] G.M. Sheldrick, SHELXL97 and SHELXS97, Acta Crystallogr. Sect A 64 (2008) 112-122. 
[19] C.K. Johnson, ORTEPII, Report ORNL-5138, Oak Ridge National Laboratory, Oak Ridge, 
Tennessee, 1976. 
[20] T.S. Basu Baul, K.S. Singh, X. Song, A. Zapata, G. Eng, A. Lyčka, A. Linden, J. 
 16 
Organomet. Chem. 689 (2004) 4702-4711. 
[21] T.S. Basu Baul, S. Dhar, N. Kharbani, S.M. Pyke, R. Butcher, F.E. Smith, Main Group Met. 
Chem. 22 (1999) 413-421. 
[22]  T.S. Basu Baul, S. Dhar, S.M. Pyke, E.R.T. Tiekink, E. Rivarola, R. Butcher, F.E. Smith, J. 
Organomet. Chem. 633 (2001) 7-17. 
[23] R. Willem, I. Verbruggen, M. Gielen, M. Biesemans, B. Mahieu, T.S. Basu Baul, E.R.T. 
Tiekink, Organometallics 17 (1998) 5758-5766. 
[24] J. Bernstein, R.E. Davis, L. Shimoni, N.-L. Chang, Angew. Chem. Int. Ed. Engl. 34 (1995) 
1555-1573. 
[25] T.S. Basu Baul, S. Dutta, E. Rivarola, R. Butcher, F.E. Smith, J. Organomet. Chem. 654 
(2002) 100-108. 
[26] T.S. Basu Baul, C. Masharing, G. Ruisi, R. Jirásko, M. Holčapek, D. de Vos, D. 
Wolstenholme, A. Linden, J. Organomet. Chem. 692 (2007) 4849-4862. 
[27] T.S. Basu Baul, S. Basu, D. De Vos, A. Linden, Invest. New Drugs 27 (2009) 419-431.  
[28] T.S. Basu Baul, C. Masharing, G. Ruisi, C. Pettinari, A. Linden, J. Inorg. Organomet. 
Polym. 19 (2009) 395-400. 
[29] P.J. Harrison, K. Lambert, T.J. King, B. Majee, J. Chem. Soc., Dalton Trans. (1983) 363-369.  
[30] T.S. Basu Baul, E.R.T. Tiekink, Z Kristallogr (NCS) 211 (1996) 489-490. 
[31] T.S. Basu Baul, W. Rynjah, E. Rivarola, A. Linden, J Organomet Chem 690 (2005) 613-621. 
 
 
 
 
 
 
 
 17 
Captions to the Figures: 
 
Fig.1. Generic structure and numbering protocol of the ligand (LHH’) where H and H’ represent 
hydroxyl and carboxyl protons, respectively. 
 
Fig.2. View of the molecule of LHH’ showing the atom-labelling scheme (50% probability 
ellipsoids).  
 
Fig.3. Three repeats of the crystallographically and chemically unique unit in the polymeric 
[Me3SnLH]n  chain structure of 1 (50% probability ellipsoids)  
 
Fig. 4. (a) The crystallographically and chemically unique unit in one of the three symmetry-
independent polymeric chains in the structure of [Bu3SnLH]n 2 (50% probability ellipsoids); (b) 
Two continuous chemical but crystallographically unique units in one of the other symmetry-
independent [Bu3SnLH]n chains in 2 (50% probability ellipsoids)." 
 
Fig. 5. The molecular structure of Ph3SnLH 3 (50% probability ellipsoids)  
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Table 1  
Crystallographic data and structure refinement parameters for the ligand LHH’ and their triorganotin(IV) 
complexes 1-3 
 LHH’ 1 2 3 
Empirical formula C15H14N2O3 C19H23Cl3N2O3Sn C27H40 N2O3Sn C33H28N2O3Sn 
Formula weight 270.29 552.36 559.22 619.19 
Crystal size (mm) 0.10 × 0.15 × 0.20 0.10 × 0.18 × 0.23 0.10 × 0.25 × 0.25 010 × 0.20 × 0.30 
Crystal shape Prism Tablet Tablet Plate 
Temperature (K) 103(1) 160(1) 160(1) 160(1) 
Crystal system Monoclinic Monoclinic Monoclinic Triclinic 
Space group C2/c  P21/c  P21/c  P
_
1  
a (Å) 11.95231(11) 14.5151(2) 31.8017(3) 9.9441(2) 
b (Å) 16.77432(14) 18.2399(2) 19.8331(2) 12.0176(2) 
c (Å) 13.53109(12) 8.9687(1) 18.1605(2) 13.4453(2) 
α (°) 90 90 90 111.9873(9) 
β (°) 104.5241(9) 103.6542(8) 104.3134(5) 90.268(1) 
γ (°) 90 90 90 108.8208(7) 
V (Å3) 2626.18(4) 2307.39(5) 11098.7(2) 1395.76(4) 
Z 8 4 16 2 
Dx (g cm-3) 1.367 1.590 1.339 1.473 
µ (mm-1) 0.798 1.474 0.948 0.952 
Transmission factors (min, max) 0.604; 1.000 0.815, 0.898 0.832, 0.911 0.849, 0.911 
2θmax (°) 153.1 58 55 60 
Reflections measured 11028 65265 191552 37409 
Independent reflections (Rint) 2736 (0.013) 6195 (0.063) 25378 (0.075) 8041 (0.045) 
Reflections with I > 2σ(I) 2552 4732 17219 7189 
Number of parameters 191 263 1236 359 
R(F) (I >2σ(I) reflns) 0.033 0.039 0.047 0.028 
wR(F2) (all data) 0.095 0.102 0.123 0.068 
GOF(F2) 1.05 1.04 1.04 1.05 
max, min Δρ (e/Å3) 0.36, -0.20 1.05, -1.10 2.72, -1.02 1.17, -1.02  
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Table 2  
Selected bond lengths (Å) and angles (º) for LHH’ 
O(1) -C(1)    1.3254(11)                    N(1) -N(2)      1.2636(11) 
O(2) -C(1)      1.2176(11) N(1) -C(7)      1.4239(11) 
O(3) -C(11)     1.3519(11) N(2) -C(8)      1.4035(11) 
    
N(2)-N(1)-C(7) 115.01(8) C(2)-C(7)-N(1) 117.62(8) 
N(1)-N(2)-C(8) 116.27(8) C(6)-C(7)-N(1) 122.23(8) 
O(2)-C(1)-O(1) 119.62(8) C(9)-C(8)-N(2)  125.94(8) 
O(2)-C(1)-C(2) 122.19(8) C(13)-C(8)-N(2)  114.53(8) 
O(1)-C(1)-C(2)   118.18(8)   
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Table 3  
Hydrogen bonding geometry (Å, º) for LHH’ 
D-H···A D-H H···A D···A D-H···A 
O(1)-H(1)···N(1) 0.90(2) 1.73(2) 2.5733(10) 155.4(17) 
O(3)-H(3)···O(2') 0.89(2) 1.945(9) 2.7885(10) 157.0(19) 
Primed atoms refer to the molecule in the symmetry related position: 1+x,-
y,1/2+z  
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Table 4  
Selected bond lengths (Å) and angles (º) for 1-3a 
 1 2b 3 
Sn(1)-O(1) 2.137(2) 2.157(2) 2.075(1)                     
Sn(1)-O(3)i 2.551(2) 2.625(2) - 
Sn(1)···O(2) 3.081(2) 3.079(3) 2.778(1)                     
Sn(1)-C(14) 2.123(3) 2.143(4) 2.119(2)                     
Sn(1)-C(15) 2.126(3) 2.138(4) 2.126(2)                     
Sn(1)-C(16) 2.113(4) 2.143(4) 2.136(2)                     
    
O(1)-Sn(1)-O(3)i 176.29(8) 173.07(9)             - 
O(1)-Sn(1)-C(14) 91.2(1) 98.1(1)              101.00(6) 
O(1)-Sn(1)-C(15) 97.7(1) 98.0(1)              118.35(6)             
O(1)-Sn(1)-C(16) 96.1(1) 89.9(1)              97.50(6)             
O(3)i-Sn(1)-C(14) 85.6(1)              86.5(1)              - 
O(3)i-Sn(1)-C(15) 85.3(1) 83.9(1)              - 
O(3)i-Sn(1)-C(16) 83.9(1) 83.5(1)              - 
C(14)-Sn(1)-C(15) 115.4(2)              120.9(2) 117.47(7)             
C(15)-Sn(1)-C(16) 126.2(2)              123.5(1) 111.17(7)             
C(16)-Sn(1)-C(14) 116.0(2) 113.0(2) 109.18(7)             
a Atom labels with superscript “i” refer to atoms from the next symmetrically-related ligand in the 
polymeric chain for 1 (Symmetry code: -x,y-1/2,-z+1/2) and 2 (Symmetry code: 1-x, 
y+1/2,3/2-z). b Only the parameters for one of the four independent fragments of 2 are given; the 
corresponding parameters for the other three fragments are very similar. 
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Table 5  
Hydrogen bonding geometry (Å, º) for 1-3a  
 
 
 
 
 
 
 
aThe H-bonding geometrical parameters for the four independent fragments of complex 2 
are in square brackets while those of complex 3 are in parentheses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D-H···A D-H H···A D···A D-H···A 
N(1)-H(1)···O(2) 0.87(4) [(0.88(4)] 
(0.82(2))    
1.87(4) 
[1.83(4))] 
(1.96(2)) 
2.611(4) 
[2.601(4)] 
(2.641(2)) 
143(3) 
[146(4)] 
(140(2)) 
N(31)-(31)···O(32) [0.90(3)] [1.85(3)] [2.606(4)] [140(3)] 
N(61)-H(61)···O(62) [0.87(3)] [1.88(3)] [2.621(4)]    [142(3)] 
N(91)-H(91)···O(92)          [0.97(4)] [1.76(4)] [2.612(4)] [144(3)] 
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